Exploring Plant-derived Compounds as Potential Sources of Natural Acetylcholinesterase Inhibitors

Abstract

Alzheimer’s disease (AD) is a neurological disorder that causes memory loss and progressive cognitive deterioration. Current therapy options for AD concentrate on symptom management rather than treating the illness’s underlying cause. The capacity of plant-based acetylcholinesterase inhibitors (AChEIs) to raise acetylcholine levels in the brain has made them a promising treatment option for AD. Acetylcholine is a neurotransmitter that is essential for memory, learning, and cognitive functions. The acetylcholinesterase (AChE) breaks down acetylcholine in AD, resulting in a shortage of this crucial neurotransmitter and causing cognitive deficits. These chemicals produced from plants can help maintain higher amounts of acetylcholine in the brain by blocking AChE, which may improve cognitive function and slow the progression of the disease. These substances have been shown to improve learning and memory, lessen amyloid-beta plaques and disease-related neuroinflammation in the brain. In addition, as compared to the synthetic medications now used to treat AD, plant-derived AChEIs have demonstrated better safety profiles and fewer adverse effects. In general, plant-based AChEIs are a new and potentially effective treatment strategy for AD. Additional research is required to further understand these substances’ mechanisms of action and efficacy. As interest in natural remedies for neurodegenerative diseases increases, AChEIs derived from plants hold significant promise to improve the quality of life in AD patients.